1. Abstract 2. Introduction 3. Indications for intestinal transplantation 4. Pre-transplant work-up 5. Type of intestinal transplant 5.1. Isolated intestine 5.2. Liver-intestine 5.3. Multivisceral transplant 5.4. Modified multivisceral transplant 6. Surgical techniques 6.1. Donor operation 6.2. Recipient operation 7. Living-related intestinal transplant 8. Immunosuppression 9. Monitoring of the...

Immunosuppressive therapy for transplanted patients exposes them to a high risk of developing posttransplantation lymphoproliferative disorders (PTLD). We report the case of a child undergoing heart transplantation at seven months of age who developed PTLD at nine years of age, diagnosed by resection of a pulmonary nodule.

Correspondence: Ann S. LaCasce, M.D., Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA. Telephone: 617-632-5959 Fax: 617-632-5890; e-mail: [email protected] Received March 20, 2006; accepted for publication April 11, 2006. ©AlphaMed Press 1083-7159/2006/$20.00/0 Abstract Post-transplant lymphoproliferative disorder is the most common malignancy, with t...

Posttransplant lymphoproliferative disorder (PTLD) is a spectrum of diseases that involves abnormal lymphoid and/or plasmacytic proliferation in patients with solid organ or hematopoietic cell transplantation. It is a condition with a low incidence of 3.5-4.3% in liver transplant (LT) recipients. This case involves a 63-year-old male with history of LT for chronic HCV induced cirrhosis who pres...

A 66-year-old woman presented with pustular lesions of her face, trunk, and limbs and an acute arthritis of the knees and elbows. She had a complex medical background and had been on immunosuppressants for three years after a liver transplant. Tissue samples from her skin lesions and synovial fluid showed acid-fast bacilli. Mycobacterium haemophilum, an atypical mycobacteria, was later grown on...

AIM OF THE STUDY Epstein-Barr virus-related post-transplant lymphoproliferative disorder (EBV-PTLD) is a serious complication after stem cell transplantation (SCT) and the number of patients at risk is increasing over time. Available data do not reflect general practice of diagnosis and treatment of this complication. MATERIAL AND METHODS In 2009 a survey on management of the pre-emptive stra...